Comparison of the Effects of Mesenchymal Stem Cells with Their Extracellular Vesicles on the Treatment of Kidney Damage Induced by Chronic Renal Artery Stenosis

Background. Chronic renal artery stenosis is considered one of the most common causes of renovascular hypertension (RH). Chronic hypoxia can lead to irreversible damage to renal tissue and to a progressive deterioration of renal function. We have previously shown that bone marrow-derived mesenchymal...

Full description

Saved in:
Bibliographic Details
Main Authors: Crysthiane Saveriano Rubiao Andre Ishiy, Milene Subtil Ormanji, Edgar Maquigussa, Rosemara Silva Ribeiro, Antonio da Silva Novaes, Mirian Aparecida Boim
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2020/8814574
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568477063315456
author Crysthiane Saveriano Rubiao Andre Ishiy
Milene Subtil Ormanji
Edgar Maquigussa
Rosemara Silva Ribeiro
Antonio da Silva Novaes
Mirian Aparecida Boim
author_facet Crysthiane Saveriano Rubiao Andre Ishiy
Milene Subtil Ormanji
Edgar Maquigussa
Rosemara Silva Ribeiro
Antonio da Silva Novaes
Mirian Aparecida Boim
author_sort Crysthiane Saveriano Rubiao Andre Ishiy
collection DOAJ
description Background. Chronic renal artery stenosis is considered one of the most common causes of renovascular hypertension (RH). Chronic hypoxia can lead to irreversible damage to renal tissue and to a progressive deterioration of renal function. We have previously shown that bone marrow-derived mesenchymal stem cells (BMSCs) improved renal parenchyma and function in a model of RH (2 kidneys, 1 clip model (2K-1C) in rats. Microvesicles (MVs) and exosomes (EXs) released by MSCs have been shown to induce effects similar to those induced by whole cells but with fewer side effects. In this study, we compared the effects of adipose-derived MSCs (ASCs) with those of the MVs and EXs released by ASCs on tissue inflammation and renal function in 2 K-1C rats. Results. Flow cytometry analysis showed that even after 15 days, ASCs were still detected in both kidneys. The expression of a stem cell homing marker (SDF1-α) was increased in ASC-treated animals in both the stenotic and contralateral kidneys. Interestingly, SDF1-α expression was also increased in MV- and EX-treated animals. A hypoxia marker (HIF1-α) was upregulated in the stenotic kidney, and treatments with ASCs, MVs, and EXs were effective in reducing the expression of this marker. Stenotic animals showed a progressive increase in systolic blood pressure (SBP), while animals treated with ASCs, MVs, and EXs showed a stabilization of SBP, and this stabilization was similar among the different treatments. Stenotic animals developed significant proteinuria, which was reduced by ASCs and MVs but not by EXs. The increased expression of Col I and TGFβ in both kidneys was reduced by all the treatments, and these treatments also effectively increased the expression of the anti-inflammatory cytokine IL-10 in both kidneys; however, only ASCs were able to reduce the overexpression of the proinflammatory cytokine IL-1β in both kidneys of 2K-1C animals. Conclusion. The results of this study demonstrated that the EVs released by ASCs produced beneficial results but with lower efficacy than whole cells. ASCs produced stronger effects in this model of renal chronic hypoxia, and the use of EVs instead of whole cells should be evaluated depending on the parameter to be corrected.
format Article
id doaj-art-183601e0e257438493d992f4fed3b165
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-183601e0e257438493d992f4fed3b1652025-02-03T00:58:52ZengWileyStem Cells International1687-966X1687-96782020-01-01202010.1155/2020/88145748814574Comparison of the Effects of Mesenchymal Stem Cells with Their Extracellular Vesicles on the Treatment of Kidney Damage Induced by Chronic Renal Artery StenosisCrysthiane Saveriano Rubiao Andre Ishiy0Milene Subtil Ormanji1Edgar Maquigussa2Rosemara Silva Ribeiro3Antonio da Silva Novaes4Mirian Aparecida Boim5Renal Division, Department of Medicine-Federal University of São Paulo, São Paulo, BrazilRenal Division, Department of Medicine-Federal University of São Paulo, São Paulo, BrazilRenal Division, Department of Medicine-Federal University of São Paulo, São Paulo, BrazilRenal Division, Department of Medicine-Federal University of São Paulo, São Paulo, BrazilRenal Division, Department of Medicine-Federal University of São Paulo, São Paulo, BrazilRenal Division, Department of Medicine-Federal University of São Paulo, São Paulo, BrazilBackground. Chronic renal artery stenosis is considered one of the most common causes of renovascular hypertension (RH). Chronic hypoxia can lead to irreversible damage to renal tissue and to a progressive deterioration of renal function. We have previously shown that bone marrow-derived mesenchymal stem cells (BMSCs) improved renal parenchyma and function in a model of RH (2 kidneys, 1 clip model (2K-1C) in rats. Microvesicles (MVs) and exosomes (EXs) released by MSCs have been shown to induce effects similar to those induced by whole cells but with fewer side effects. In this study, we compared the effects of adipose-derived MSCs (ASCs) with those of the MVs and EXs released by ASCs on tissue inflammation and renal function in 2 K-1C rats. Results. Flow cytometry analysis showed that even after 15 days, ASCs were still detected in both kidneys. The expression of a stem cell homing marker (SDF1-α) was increased in ASC-treated animals in both the stenotic and contralateral kidneys. Interestingly, SDF1-α expression was also increased in MV- and EX-treated animals. A hypoxia marker (HIF1-α) was upregulated in the stenotic kidney, and treatments with ASCs, MVs, and EXs were effective in reducing the expression of this marker. Stenotic animals showed a progressive increase in systolic blood pressure (SBP), while animals treated with ASCs, MVs, and EXs showed a stabilization of SBP, and this stabilization was similar among the different treatments. Stenotic animals developed significant proteinuria, which was reduced by ASCs and MVs but not by EXs. The increased expression of Col I and TGFβ in both kidneys was reduced by all the treatments, and these treatments also effectively increased the expression of the anti-inflammatory cytokine IL-10 in both kidneys; however, only ASCs were able to reduce the overexpression of the proinflammatory cytokine IL-1β in both kidneys of 2K-1C animals. Conclusion. The results of this study demonstrated that the EVs released by ASCs produced beneficial results but with lower efficacy than whole cells. ASCs produced stronger effects in this model of renal chronic hypoxia, and the use of EVs instead of whole cells should be evaluated depending on the parameter to be corrected.http://dx.doi.org/10.1155/2020/8814574
spellingShingle Crysthiane Saveriano Rubiao Andre Ishiy
Milene Subtil Ormanji
Edgar Maquigussa
Rosemara Silva Ribeiro
Antonio da Silva Novaes
Mirian Aparecida Boim
Comparison of the Effects of Mesenchymal Stem Cells with Their Extracellular Vesicles on the Treatment of Kidney Damage Induced by Chronic Renal Artery Stenosis
Stem Cells International
title Comparison of the Effects of Mesenchymal Stem Cells with Their Extracellular Vesicles on the Treatment of Kidney Damage Induced by Chronic Renal Artery Stenosis
title_full Comparison of the Effects of Mesenchymal Stem Cells with Their Extracellular Vesicles on the Treatment of Kidney Damage Induced by Chronic Renal Artery Stenosis
title_fullStr Comparison of the Effects of Mesenchymal Stem Cells with Their Extracellular Vesicles on the Treatment of Kidney Damage Induced by Chronic Renal Artery Stenosis
title_full_unstemmed Comparison of the Effects of Mesenchymal Stem Cells with Their Extracellular Vesicles on the Treatment of Kidney Damage Induced by Chronic Renal Artery Stenosis
title_short Comparison of the Effects of Mesenchymal Stem Cells with Their Extracellular Vesicles on the Treatment of Kidney Damage Induced by Chronic Renal Artery Stenosis
title_sort comparison of the effects of mesenchymal stem cells with their extracellular vesicles on the treatment of kidney damage induced by chronic renal artery stenosis
url http://dx.doi.org/10.1155/2020/8814574
work_keys_str_mv AT crysthianesaverianorubiaoandreishiy comparisonoftheeffectsofmesenchymalstemcellswiththeirextracellularvesiclesonthetreatmentofkidneydamageinducedbychronicrenalarterystenosis
AT milenesubtilormanji comparisonoftheeffectsofmesenchymalstemcellswiththeirextracellularvesiclesonthetreatmentofkidneydamageinducedbychronicrenalarterystenosis
AT edgarmaquigussa comparisonoftheeffectsofmesenchymalstemcellswiththeirextracellularvesiclesonthetreatmentofkidneydamageinducedbychronicrenalarterystenosis
AT rosemarasilvaribeiro comparisonoftheeffectsofmesenchymalstemcellswiththeirextracellularvesiclesonthetreatmentofkidneydamageinducedbychronicrenalarterystenosis
AT antoniodasilvanovaes comparisonoftheeffectsofmesenchymalstemcellswiththeirextracellularvesiclesonthetreatmentofkidneydamageinducedbychronicrenalarterystenosis
AT mirianaparecidaboim comparisonoftheeffectsofmesenchymalstemcellswiththeirextracellularvesiclesonthetreatmentofkidneydamageinducedbychronicrenalarterystenosis